Inhibitory effects of bee venom on Propionibacterium acnes-induced inflammatory skin disease in an animal model

An,Hyun-Jin; Lee,Woo-Ram; Kim,Kyung-Hyun; Kim,Jung-Yeon; Lee,Sun-Jae; Han,Sang-Mi; Lee,Kwang-Gill; Lee,Chong-Kee; Park,Kwan-Kyu

doi:10.3892/ijmm.2014.1933

Inhibitory effects of bee venom on Propionibacterium acnes-induced inflammatory skin disease in an animal model

Authors:
- Hyun-Jin An
- Woo-Ram Lee
- Kyung-Hyun Kim
- Jung-Yeon Kim
- Sun-Jae Lee
- Sang-Mi Han
- Kwang-Gill Lee
- Chong-Kee Lee
- Kwan-Kyu Park
View Affiliations

Affiliations: Department of Pathology, College of Medicine, Catholic University of Daegu, Daegu, Republic of Korea, Department of Agricultural Biology, National Institute of Agricultural Science and Technology, Wanju, Republic of Korea, Department of Immunology, College of Medicine, Catholic University of Daegu, Daegu, Republic of Korea
Published online on: September 12, 2014 https://doi.org/10.3892/ijmm.2014.1933
Pages: 1341-1348

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Propionibacterium acnes (P. acnes) is a major contributing factor to the inflammatory component of acne. The many prescription medications for acne allow for a large number of potential combination treatments. However, several antibiotics, apart from their antibacterial effects, exert side‑effects, such as the suppression of host inflammatory responses. Purified bee venom (BV) is a natural toxin produced by honeybees (Apis mellifera L.). BV has been widely used as a traditional medicine for various diseases. In the present study, to investigate the therapeutic effects of BV against P. acnes-induced inflammatory skin disease, P. acnes was intradermally injected into the ears of mice. After the injection, BV was applied to the skin surface of the right ear. Histological observation revealed that P. acnes induced a considerable increase in the number of infiltrated inflammatory cells. However, treatment with BV markedly reduced these reactions compared with the P. acnes-injected mice not treated with BV. Moreover, the expression levels of tumor necrosis factor (TNF)-α, and interleukin (IL)-1β were significantly reduced in the BV-treated mice compared with the untreated P. acnes-injected mice. In addition, treatment with BV significantly inhibited Toll-like receptor (TLR)2 and CD14 expression in P. acnes-injected tissue. The binding activity of nuclear factor-κB (NF-κB) and activator protein (AP)-1 was markedly suppressed following treatment with BV. The results from our study, using an animal model, indicate that BV exerts an inhibitory effect on inflammatory skin diseases. In conclusion, our data indicate that BV has potential for use as an anti-acne agent and may be useful in the pharmaceutical and cosmetics industries.

View Figures

View References

1	Tsai HH, Lee WR, Wang PH, Cheng KT, Chen YC and Shen SC: Propionibacterium acnes-induced iNOS and COX-2 protein expression via ROS-dependent NF-κB and AP-1 activation in macrophages. J Dermatol Sci. 69:122–131. 2013. View Article : Google Scholar
2	Jung MK, Ha S, Son JA, et al: Polyphenon-60 displays a therapeutic effect on acne by suppression of TLR2 and IL-8 expression via down-regulating the ERK1/2 pathway. Arch Dermatol Res. 304:655–663. 2012. View Article : Google Scholar : PubMed/NCBI
3	Mak TN, Fischer N, Laube B, et al: Propionibacterium acnes host cell tropism contributes to vimentin-mediated invasion and induction of inflammation. Cell Microbiol. 14:1720–1733. 2012. View Article : Google Scholar
4	Nakatsuji T, Kao MC, Fang JY, et al: Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J Invest Dermatol. 129:2480–2488. 2009. View Article : Google Scholar : PubMed/NCBI
5	Pawin H, Beylot C, Chivot M, et al: Physiopathology of acne vulgaris: recent data, new understanding of the treatments. Eur J Dermatol. 14:4–12. 2004.PubMed/NCBI
6	Vowels BR, Yang S and Leyden JJ: Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun. 63:3158–3165. 1995.PubMed/NCBI
7	Kim J: Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology. 211:193–198. 2005. View Article : Google Scholar : PubMed/NCBI
8	Medzhitov R, Preston-Hurlburt P and Janeway CA Jr: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388:394–397. 1997. View Article : Google Scholar : PubMed/NCBI
9	Jugeau S, Tenaud I, Knol AC, et al: Induction of toll-like receptors by Propionibacterium acnes. Br J Dermatol. 153:1105–1113. 2005. View Article : Google Scholar : PubMed/NCBI
10	Kim J, Ochoa MT, Krutzik SR, et al: Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol. 169:1535–1541. 2002. View Article : Google Scholar : PubMed/NCBI
11	Williams HC, Dellavalle RP and Garner S: Acne vulgaris. Lancet. 379:361–372. 2012. View Article : Google Scholar : PubMed/NCBI
12	Titus S and Hodge J: Diagnosis and treatment of acne. Am Fam Physician. 86:734–740. 2012.
13	Feldman S, Careccia RE, Barham KL and Hancox J: Diagnosis and treatment of acne. Am Fam Physician. 69:2123–2130. 2004.
14	Labro MT: Immunomodulation by antibacterial agents. Is it clinically relevant? Drugs. 45:319–328. 1993. View Article : Google Scholar : PubMed/NCBI
15	Ayangco L and Sheridan PJ: Minocycline-induced staining of torus palatinus and alveolar bone. J Periodontol. 74:669–671. 2003. View Article : Google Scholar : PubMed/NCBI
16	Ramakrishna J, Johnson AR and Banner BF: Long-term minocycline use for acne in healthy adolescents can cause severe autoimmune hepatitis. J Clin Gastroenterol. 43:787–790. 2009. View Article : Google Scholar : PubMed/NCBI
17	Billingham ME, Morley J, Hanson JM, Shipolini RA and Vernon CA: Letter: An anti-inflammatory peptide from bee venom. Nature. 245:163–164. 1973. View Article : Google Scholar : PubMed/NCBI
18	Son DJ, Lee JW, Lee YH, Song HS, Lee CK and Hong JT: Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther. 115:246–270. 2007. View Article : Google Scholar : PubMed/NCBI
19	Kwon YB, Lee JD, Lee HJ, et al: Bee venom injection into an acupuncture point reduces arthritis associated edema and nociceptive responses. Pain. 90:271–280. 2001. View Article : Google Scholar : PubMed/NCBI
20	Pérez-Payá E, Houghten RA and Blondelle SE: The role of amphipathicity in the folding, self-association and biological activity of multiple subunit small proteins. J Biol Chem. 270:1048–1056. 1995.PubMed/NCBI
21	Park HJ, Lee SH, Son DJ, et al: Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit. Arthritis Rheum. 50:3504–3515. 2004. View Article : Google Scholar : PubMed/NCBI
22	Khalaf H, Jass J and Olsson PE: Differential cytokine regulation by NF-kappaB and AP-1 in Jurkat T-cells. BMC Immunol. 11:262010. View Article : Google Scholar : PubMed/NCBI
23	Dryden MS: Skin and soft tissue infection: microbiology and epidemiology. Int J Antimicrob Agents. 34(Suppl 1): S2–S7. 2009. View Article : Google Scholar : PubMed/NCBI
24	Sohail MR, Gray AL, Baddour LM, Tleyjeh IM and Virk A: Infective endocarditis due to Propionibacterium species. Clin Microbiol Infect. 15:387–394. 2009. View Article : Google Scholar : PubMed/NCBI
25	Dessinioti C and Katsambas AD: The role of Propionibacterium acnes in acne pathogenesis: facts and controversies. Clin Dermatol. 28:2–7. 2010.
26	Grange PA, Raingeaud J, Calvez V and Dupin N: Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-kappaB and MAPK pathways. J Dermatol Sci. 56:106–112. 2009.PubMed/NCBI
27	Fivenson DP, Breneman DL, Rosen GB, Hersh CS, Cardone S and Mutasim D: Nicotinamide and tetracycline therapy of bullous pemphigoid. Arch Dermatol. 130:753–758. 1994. View Article : Google Scholar : PubMed/NCBI
28	Zemtsov A and Neldner KH: Successful treatment of dermatitis herpetiformis with tetracycline and nicotinamide in a patient unable to tolerate dapsone. J Am Acad Dermatol. 28:505–506. 1993. View Article : Google Scholar : PubMed/NCBI
29	Handfield-Jones S, Jones S and Peachey R: High dose nicotinamide in the treatment of necrobiosis lipoidica. Br J Dermatol. 118:693–696. 1988. View Article : Google Scholar : PubMed/NCBI
30	Lee WR, Park JH, Kim KH, Park YY, Han SM and Park KK: Protective effects of melittin on transforming growth factor-beta1 injury to hepatocytes via anti-apoptotic mechanism. Toxicol Appl Pharmacol. 256:209–215. 2011. View Article : Google Scholar : PubMed/NCBI
31	Lee WR, Kim SJ, Park JH, et al: Bee venom reduces atherosclerotic lesion formation via anti-inflammatory mechanism. Am J Chin Med. 38:1077–1092. 2010. View Article : Google Scholar : PubMed/NCBI
32	Han SM, Lee KG, Yeo JH, Baek HJ and Park KK: Antibacterial and anti-inflammatory effects of honeybee (Apis mellifera) venom against acne-inducing bacteria. J Med Plants Res. 4:459–464. 2010.
33	Lyte P, Sur R, Nigam A and Southall MD: Heat-killed Propionibacterium acnes is capable of inducing inflammatory responses in skin. Exp Dermatol. 18:1070–1072. 2009.
34	Mandell L, Moran AP, Cocchiarella A, et al: Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4. Infect Immun. 72:6446–6454. 2004.PubMed/NCBI
35	Köllisch G, Kalali BN, Voelcker V, et al: Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology. 114:531–541. 2005.PubMed/NCBI
36	Kurokawa I, Danby FW, Ju Q, et al: New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol. 18:821–832. 2009. View Article : Google Scholar : PubMed/NCBI
37	Scharf S, Hippenstiel S, Flieger A, Suttorp N and N’Guessan PD: Induction of human β-defensin-2 in pulmonary epithelial cells by Legionella pneumophila: involvement of TLR2 and TLR5, p38 MAPK, JNK, NF-kappaB, and AP-1. Am J Physiol Lung Cell Mol Physiol. 298:L687–L695. 2010.
38	Kang S, Cho S, Chung JH, Hammerberg C, Fisher GJ and Voorhees JJ: Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo. Am J Pathol. 166:1691–1699. 2005. View Article : Google Scholar